Form 4: Neuronetics Director Sheryl Conley Receives 25,000 Restricted Stock Units

Director Sheryl Conley of Neuronetics, Inc. reports the acquisition of 25,000 restricted stock units (RSUs) on May 30, 2024.

Summary

• Sheryl Conley, a director at Neuronetics, Inc., acquired 25,000 restricted stock units on May 30, 2024.
• These RSUs vest on the earlier of May 30, 2025, or Conley's Board-approved separation of service, contingent upon continuous service.
• Each RSU represents a contingent right to receive one share of Neuronetics' common stock.
• Following this transaction, Conley directly owns 139,946 shares of common stock.

Sentiment

Score: 6

Explanation: The sentiment is neutral. It's a standard disclosure of stock units granted to a director. While it indicates confidence, it's not overwhelmingly positive or negative.

Positives

• The acquisition of RSUs by a director signals confidence in the company's future.

Future Outlook

The vesting of the RSUs is contingent upon continued service, aligning the director's interests with the company's long-term performance.

Industry Context

Form 4 filings are standard practice for reporting changes in beneficial ownership by company insiders, providing transparency to investors.

Stakeholder Impact

• Shareholders are informed about changes in ownership by a company director.

Key Dates